A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3037 participants.
Also called NCT02293395
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 3,037 participants
- Registry
-
NCT02293395 -
2014-004266-26
-
- Other papers using this trial's data
- Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
- P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czechia, Denmark, France, Hungary, Japan, Netherlands, Poland, Russia, South Korea, Spain, Sweden, Türkiye, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT02293395. Randomized; double masking; primary purpose treatment. Start 2015-04-20 (actual); primary completion 2016-10-14 (actual). Results posted on 2017-11-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
- Acronym
- GEMINI ACS 1
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Acetylsalicylic acid
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Janssen Research & Development, LLC
- Collaborator
- Bayer
- Collaborator
- Duke Clinical Research Institute
- Collaborator
- Harvard Medical School (HMS and HSDM)
Record details
- Record id
cardio:ct-nct02293395- Content hash
228be99d12622e4b245ce096f9d3d4ef6f827865ecb4c65afa68b7f40d13d67d